The Upstream Mevalonate Precursor for CoQ10, Vitamin K2, Testosterone, and Muscle Maintenance
Geranylgeraniol (GG) is a 20-carbon isoprenoid alcohol produced in every human cell via the mevalonate pathway, the same metabolic route responsible for cholesterol, CoQ10, Vitamin K2 (MK-4), and steroid hormones. GG sits at an upstream junction enabling five interconnected biological systems simultaneously.
GG production naturally declines with age, and statin medications reduce it further. GG supplementation can restore downstream CoQ10, K2, and testosterone pathways without interfering with the cholesterol-lowering process. Wellness Extract uses GG-Gold®, standardized annatto-derived geranylgeraniol.
Geranylgeraniol (GG), also known as GGOH or tetraprenol, is a 20-carbon isoprenoid alcohol with molecular formula C₂₀H₃₄O. It's produced inside every human cell via the mevalonate pathway, the same pathway responsible for cholesterol, CoQ10, Vitamin K2, and steroid hormones. GG sits at a critical upstream junction: when replenished, it enables the body to restore five interconnected biological systems simultaneously.
GG production naturally declines with age. Statin medications reduce it further by blocking HMG-CoA reductase, the pathway's first enzyme. GG supplementation can bypass this depletion, restoring the body's capacity to produce CoQ10, K2, and testosterone without interfering with cholesterol lowering.
GG enables CoQ10 synthesis, Vitamin K2 (MK-4) production, muscle protein maintenance, testosterone production, and bone cell protection simultaneously, making it uniquely comprehensive compared to downstream supplements like standalone CoQ10.
Statins inhibit HMG-CoA reductase, the first step of the mevalonate pathway, reducing both cholesterol and GG/CoQ10 downstream. GG supplementation can replenish these downstream pathways without interfering with cholesterol lowering.
Wellness Extract uses GG-Gold®, standardized geranylgeraniol derived from annatto seeds, the same plant source as DeltaGold® tocotrienols. Available in standalone and combination products (Eannatto 150+).
GG's upstream metabolic position makes it uniquely comprehensive. While CoQ10 supplements provide only the final product and statins block the entire pathway, GG works upstream to restore multiple downstream systems simultaneously.
Lab studies with C2C12 muscle cells found GG protected against statin-induced cellular damage by restoring mitochondrial membrane potential and reducing oxidative stress, without affecting the statin's cholesterol-lowering action.[1]
GG is a direct biosynthetic precursor for MK-4, the animal tissue form of Vitamin K2 essential for bone health and arterial calcification prevention. GGPP derived from GG provides the geranylgeranyl side chain that UBIAD1 needs to synthesize K2.[3]
GG provides geranylgeranyl groups required for prenylation of RAP1 proteins involved in muscle cell differentiation. In C2C12 cells, GG reversed statin-induced cell viability loss. An animal model showed oral GG suppressed Atrogin-1 and reduced muscle atrophy.[4]
In a Leydig cell model, GG increased testosterone via cAMP/PKA/StAR signaling. An 8-week human RCT found men with baseline testosterone below 700 ng/dL showed +7.5% total, +15.0% free, and +14.8% bioavailable testosterone with GG vs. placebo.[7]
Nitrogen-containing bisphosphonates deplete GGPP and impair prenylation in osteoblasts. In cultured human bone cells, GG reversed some of these inhibitory effects under laboratory conditions.[8]
GG is converted to geranylgeranyl pyrophosphate (GGPP), required for protein geranylgeranylation, the process by which signaling proteins attach to cell membranes to function. Disruptions from aging or statin use impair signaling across immune, muscle, and bone cells.
Human clinical evidence for GG is still emerging; the strongest evidence is from an 8-week human RCT and cell/animal studies. Study types are noted. Not intended to diagnose, treat, cure, or prevent any disease.
In vitro studies found GG protected muscle cells from statin-induced myotoxicity by restoring RAP1 prenylation and promoting cytoprotective autophagy. A 12-week double-blind RCT at Texas Tech (NCT05312424) is evaluating GG for SAMS in humans; results awaited.[1]
Experimental research found GG supported CoQ10 synthesis and mitochondrial energy pathways in human cell models. An 8-week dose-escalation RCT in 66 healthy adults confirmed safety with no adverse changes in complete blood count or metabolic panel at 150–300 mg/day.[7]
In an 8-week double-blind placebo-controlled trial, men with baseline testosterone below 700 ng/dL showed +7.5% total testosterone, +15.0% free testosterone, and +14.8% bioavailable testosterone with GG vs. placebo. Men with normal baseline did not show the same effect.[7]
A 2020 animal study found oral GG suppressed Atrogin-1 and reduced denervation-induced muscle atrophy. C2C12 cell studies (2018) found GG reduced muscle atrophy markers while promoting muscle cell differentiation.[5]
In cultured human osteoblasts and osteoclasts, GG restored cell viability and bone cell markers suppressed by zoledronate treatment, addressing the MRONJ (medication-related osteonecrosis of the jaw) mechanism at the cellular level.[8]
Published human research has primarily used 150–300 mg/day in dose-escalation protocols. Take with a fat-containing meal; GG is fat-soluble.
| Source | Details |
|---|---|
| Annatto seeds | Richest natural source; co-occurring with tocotrienols |
| Olive / coconut / palm oil | Small amounts; not sufficient for therapeutic doses |
GG occurs in small amounts in annatto, olive oil, coconut oil, and palm oil, all too low for research-level doses. Dietary GG amounts are far below the 150–300 mg range studied in research. Standardized supplementation is the practical route.
GG-Gold® available in standalone (GG-Essential®) and combination (Eannatto 150+) softgels.
| Dose | Details |
|---|---|
| 150 mg/day | Starting dose in human safety RCT; used for first 4 weeks |
| 150–300 mg/day | Full dose-escalation range in published human RCT; confirmed safe |
| 300 mg/day | Maximum dose in completed human trials; dose showing testosterone effects |
Long-term human data beyond 8 weeks is limited. Consult a healthcare provider, especially if taking statins, bisphosphonates, or cholesterol medication.
GG from annatto offers a unique advantage: the same plant that provides DeltaGold® tocotrienols also yields GG-Gold® geranylgeraniol, the only source where both compounds naturally co-occur and are tocopherol-free.
Bixa orellana seeds naturally contain both tocotrienols and geranylgeraniol, the only plant source where both mevalonate pathway compounds co-occur.
Standardized geranylgeraniol from annatto. The form used in published safety and efficacy research. Co-sourced alongside DeltaGold® tocotrienols.
GG-Essential® provides standalone GG. Eannatto 150+ combines GG-Gold® with DeltaGold® tocotrienols for coordinated mevalonate pathway support.
GG addresses upstream CoQ10, K2, and testosterone restoration while tocotrienols provide downstream antioxidant and cholesterol-modulating effects.
GG Essential® delivers 150 mg of patented GG-Gold® trans-geranylgeraniol in every softgel. GG helps support key pathways involved in CoQ10 production, healthy muscle function, bone metabolism, and hormone synthesis.
Human clinical evidence for GG is still emerging. The 2023 RCT represents the strongest available human data.
Jaskiewicz et al. showed GG protected cells from statin toxicity while preserving isoprenoid activity without affecting cholesterol lowering.
[1]GG supported endogenous CoQ10 synthesis and mitochondrial energy pathways in HepG2 and THP-1 cell models.
[2]GGPP from GG provides the geranylgeranyl side chain required by UBIAD1 to synthesize MK-4.
[3]GG reduced Atrogin-1 and promoted muscle cell differentiation through geranylgeranylation of RAP1 proteins.
[4]Oral GG supplementation suppressed Atrogin-1 and reduced denervation-induced muscle atrophy in vivo.
[5]GG increased testosterone and progesterone in Leydig cells by activating cAMP/PKA and elevating StAR.
[6]8-week dose-escalation RCT confirmed safety. Men with T below 700 ng/dL: +7.5% total, +15% free testosterone vs. placebo.
[7]GG restored cell viability and bone marker expression suppressed by bisphosphonate treatment in cultured human bone cells.
[8]GG is a 20-carbon isoprenoid produced in every cell via the mevalonate pathway. It sits at an upstream junction enabling CoQ10, Vitamin K2 (MK-4), muscle proteins, and testosterone production simultaneously. It declines with age and is further reduced by statin use.
Cell and animal studies suggest GG protects muscle cells from statin-induced damage by restoring CoQ10 precursors and prenylation of key proteins, without interfering with the statin's cholesterol-lowering action. A human RCT is underway at Texas Tech (NCT05312424).
In an 8-week human RCT, men with baseline testosterone below 700 ng/dL saw increases in total, free, and bioavailable testosterone with GG vs. placebo. Men with normal baseline testosterone did not show the same effect. This is a small trial and further confirmation is needed.
No. CoQ10 is a downstream product of the mevalonate pathway. GG sits upstream; it provides precursors the body uses to synthesize CoQ10 endogenously. Both have distinct uses depending on the individual's situation and goals.
Published human research has used 150–300 mg/day in an 8-week dose-escalation protocol, confirmed safe with no adverse changes in blood count or metabolic panel. Long-term data beyond 8 weeks is limited.
Click any footnote [n] or this header to expand the full reference list.
Jaskiewicz et al., 2018: GG restored mitochondrial function in statin-treated cells, British Journal of Pharmacology — View on PubMed
Campia et al., 2009: GG supported CoQ10 and mitochondrial pathways, Cell study — View on PubMed
Schumacher & Nakagawa: GGPP from GG as direct K2 (MK-4) precursor via UBIAD1, Mechanistic study — View on PubMed
Jaskiewicz et al., 2018: GG reduced muscle atrophy markers in C2C12 cells — View on PubMed
Miyawaki et al., 2020: Oral GG suppressed muscle atrophy, Animal study — View on PubMed
Ho et al., 2016: GG increased testosterone via cAMP/PKA/StAR, Leydig cell model — View on PubMed
Gheith et al., 2023: GG safety and testosterone RCT (n=66), Nutraceuticals — View source
Jung/Feldman, 2023–2024: GG reversed bisphosphonate-induced bone cell damage, In vitro — View on PubMed
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information on this page is provided for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting any new supplement.
Join 25,000+ who get health tips, wellness hacks & anti-aging secrets delivered fresh each week.
Thanks for subscribing!
This email has been registered!
| Product | SKU | Description | Collection | Availability | Product type | Other details |
|---|